Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Mood Disorders Archetypes • Depression – Major Depression • Mania – Bipolar Disorder (Manic-Depression) Phenomenology: The Mental Status Exam • • • • • • General Appearance Emotional Thought Cognition Judgment and Insight Reliability General Appearance • Depression • Mania Emotions: Depression • Mood – Dysphoric – Irritable, angry – Apathetic • Affect – Blunted, sad, constricted Emotions: Mania • Mood – Euphoric – Irritable • Affect – Heightened, dramatic, labile Thought: Depression • Process – Slowed processing • Thought blocking • Content • Everything’s awful • Guilty, self-deprecating • Delusional Thought: Mania • Process – Rapid – Pressured speech – Loosening of Associations • Content – Grandiose – Delusions Cognition • Depression – – – – Poor attention Registration Effort “Pseudodementia” • Mania – Distractible – Concentration – May seem brighter, more clever Insight and Judgment • Depression – Unrealistically negative • Mania – Unrealistically positive – Or just plain bad Diagnosis and Criteria • Episodes Versus Disorders Episodes • • • • Major depressive Manic Mixed Hypomanic Major Depressive Episode • Time – 2 weeks • Change – From previous functioning • Symptoms – 5 or more – 1 has to be depressed mood or anhedonia • Global Criteria Symptoms of Major Depressive Episode • “Sig E Caps” – – – – – – – – Sleep Interest Guilt Energy Concentration Appetite Psychomotor retardation Suicide • 5 or more Manic Episode • Time – 1 week • Symptom list – 3 or more • Global Criteria Symptoms of Manic Episode – – – – – – – Grandiosity Decreased need for sleep Pressured Speech Flight of Ideas Distractibility Increased Activity/Agitation Risky Activities • 3 or more The Disorders Major Depressive Disorder • “Classic Depression” • Major Depressive Episode • Rule outs – Some other disorder – History of mania/hypomania Bipolar Disorder I • Classic “Manic-Depression” • At least one – Manic or, – Mixed episode Epidemiology • Depression – – – – 5-7% 2:1 ♀:♂ $53 billion/year in US World: most costly (developed) Epidemiology • Bipolar Disorders – 1% – ~1:1 ♀:♂ Etiology and Pathophysiology Genetics • Family studies – Higher rates – Breed true? • Twin Studies – Mono:Di ~4:1 • Linkage studies – Numerous (? Consistency) – Recent: Zubenko, Am J Genetics Social/Environmental • Response to Loss – ex. Animal models • Other stress – Ex. Learned helplessness • What is role of social stress? – Ex. Nemeroff et al. Neurotransmission • Neurochemical hypotheses – Catecholamine hypothesis • Norepinephrine – Ex. Axelrod – Depletions models • Serotonin – Refinements • Imbalances • Receptors • 2nd messengers Neuroimaging • Stroke data – Dominant frontal – Basal ganglia • Fx Imaging Other Physiological Findings • Neurophysiology – Circadian rhythms and sleep • Neuroendocrine – HPA axis • DST Differential Diagnosis “We’re not living happily ever after any more” Differential Diagnosis • • • • Psychiatric Disorders Medical Disorders Substance Induced Reactive disorders – Adjustment disorders – Normal reactions Comorbidity • • • • • Anxiety disorders Substance abuse Psychotic disorders Personality disorders Depression in the medically ill. Comorbidity Course and Prognosis of Mood Disorders Course and Prognosis of Mood Disorders • Recovery • Relapse • Recurrence 90 80 70 60 50 40 30 20 10 0 0.5 1 2 Recovery 4 5 Predictors • # Episodes • Length of episodes • Symptoms – # and type • Comorbidity Risk of Suicide • Depression – 10-15% severe (hosp) pts Treatment “It is unfortunate that I didn’t get your care earlier, Mrs. Perkins.” Treatment • Depression – Pharmacological – Psychotherapy – Other somatic treatments Antidepressants Antidepressants • 1st generation – Monoamine Oxidase Inhibitors (MAOIs) – Tricyclic Antidepressants (TCAs) • 2nd – Serotonin reuptake Inhibitors (SSRIs) – Other specifics (Buproprion, Trazodone) • 3rd – Venlafaxine, Mirtazapine, Nefazodone Mechanisms of action • Monoamine Action – Increase • Norepinephrine • Serotonin – Various mechanisms • Inhibition of catabolism (MAOIs) • Reuptake inhibition (TCAs, SSRIs, Venlafaxine) • Direct effects (agonism/antagonism) (some 3rd gen) Side effects • Predicable – Anticholinergic – Antihistaminic – Serotonergic • Idiopathic Choice of antidepressant • Best? • Fastest? • Predictors of response – Past history – Family history • Major difference – Side effects Treatment failure • Inadequate dose • Inadequate time • Nonadherence Strategies for failure • Choices – Increase dose? – Augment? – New drug? Lithium Thyroid hormone Stimulants Atypical Antipsychotics 2nd Antidepressant Long term treatment • • • • Recurrent depression (3+) Chronic depression (2 years) Double depression Others Psychotherapy • Cognitive behavioral therapy • Interpersonal therapy • Others Medications versus therapy • • • • Severe depression Moderate depression Combination treatment Prevention Other treatments • ECT • TMH • Vagal nerve stimulation ECT • Maybe the best. • Medication failure • Real serious depression • Time sensitive • So why don’t we give everybody ECT? Bipolar Disorder • Lithium • Antipsychotics • Anticonvulsants Lithium • • • • • • First line Best for mania 2 weeks for effect Therapeutic index Side effects Acute and preventive Anticonvulsants • • • • • • • • Sodium Valproate Carbamazapine Lamotrigine Gabapentin Antimanic Antidepressant Prevention Side effects Antipsychotics • • • • Atypical (olanzapine) Classic May be as effective Early and late effect Sedatives • Acute use Other Diagnoses Other Episodes • Mixed • Hypomanic Other Mood Disorders • • • • • • Dysthymic Disorder Cyclothymic Disorder Bipolar II Due to a generalized medical condition Substance Induced NOS